Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

M. W. DeGregorio, W. M F Lee, C. A. Ries

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Ninety-three hospitalizations of 70 patients, who underwent induction chemotherapy for acute leukemia to determine the effectiveness of oral nystatin in preventing oropharyngeal and systemic candidiasis were reviewed. Sixty-two percent of patients who received prophylactic nystatin and 58% of patients who did not receive nystatin developed oropharyngeal candidiasis; 11% of patients who received prophylaxis and 21% of those who did not receive prophylaxis developed systemic candidiasis. The use of oral nystatin did not significantly diminish the risk of developing either type of Candida infection. Oropharyngeal candidiasis occurred more commonly in patients who had severe and prolonged leukopenia, had received more parenteral antibiotics, and had developed chemotherapy-induced mucositis. Systemic candidiasis developed almost exclusively in patients who had prior oropharyngeal candidiasis. Guidelines for the empiric use of amphotericin B in these patients are provided.

Original languageEnglish (US)
Pages (from-to)2780-2784
Number of pages5
JournalCancer
Volume50
Issue number12
StatePublished - 1982

Fingerprint

Nystatin
Candida
Leukemia
Infection
Candidiasis
Mucositis
Induction Chemotherapy
Leukopenia
Amphotericin B
Systemic candidiasis
Hospitalization
Guidelines
Anti-Bacterial Agents
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Candida infections in patients with acute leukemia : Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis. / DeGregorio, M. W.; Lee, W. M F; Ries, C. A.

In: Cancer, Vol. 50, No. 12, 1982, p. 2780-2784.

Research output: Contribution to journalArticle

@article{63821bded88b4705913f779105e000e8,
title = "Candida infections in patients with acute leukemia: Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis",
abstract = "Ninety-three hospitalizations of 70 patients, who underwent induction chemotherapy for acute leukemia to determine the effectiveness of oral nystatin in preventing oropharyngeal and systemic candidiasis were reviewed. Sixty-two percent of patients who received prophylactic nystatin and 58{\%} of patients who did not receive nystatin developed oropharyngeal candidiasis; 11{\%} of patients who received prophylaxis and 21{\%} of those who did not receive prophylaxis developed systemic candidiasis. The use of oral nystatin did not significantly diminish the risk of developing either type of Candida infection. Oropharyngeal candidiasis occurred more commonly in patients who had severe and prolonged leukopenia, had received more parenteral antibiotics, and had developed chemotherapy-induced mucositis. Systemic candidiasis developed almost exclusively in patients who had prior oropharyngeal candidiasis. Guidelines for the empiric use of amphotericin B in these patients are provided.",
author = "DeGregorio, {M. W.} and Lee, {W. M F} and Ries, {C. A.}",
year = "1982",
language = "English (US)",
volume = "50",
pages = "2780--2784",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "12",

}

TY - JOUR

T1 - Candida infections in patients with acute leukemia

T2 - Ineffectiveness of nystatin prophylaxis and relationship between oropharyngeal and systemic candidiasis

AU - DeGregorio, M. W.

AU - Lee, W. M F

AU - Ries, C. A.

PY - 1982

Y1 - 1982

N2 - Ninety-three hospitalizations of 70 patients, who underwent induction chemotherapy for acute leukemia to determine the effectiveness of oral nystatin in preventing oropharyngeal and systemic candidiasis were reviewed. Sixty-two percent of patients who received prophylactic nystatin and 58% of patients who did not receive nystatin developed oropharyngeal candidiasis; 11% of patients who received prophylaxis and 21% of those who did not receive prophylaxis developed systemic candidiasis. The use of oral nystatin did not significantly diminish the risk of developing either type of Candida infection. Oropharyngeal candidiasis occurred more commonly in patients who had severe and prolonged leukopenia, had received more parenteral antibiotics, and had developed chemotherapy-induced mucositis. Systemic candidiasis developed almost exclusively in patients who had prior oropharyngeal candidiasis. Guidelines for the empiric use of amphotericin B in these patients are provided.

AB - Ninety-three hospitalizations of 70 patients, who underwent induction chemotherapy for acute leukemia to determine the effectiveness of oral nystatin in preventing oropharyngeal and systemic candidiasis were reviewed. Sixty-two percent of patients who received prophylactic nystatin and 58% of patients who did not receive nystatin developed oropharyngeal candidiasis; 11% of patients who received prophylaxis and 21% of those who did not receive prophylaxis developed systemic candidiasis. The use of oral nystatin did not significantly diminish the risk of developing either type of Candida infection. Oropharyngeal candidiasis occurred more commonly in patients who had severe and prolonged leukopenia, had received more parenteral antibiotics, and had developed chemotherapy-induced mucositis. Systemic candidiasis developed almost exclusively in patients who had prior oropharyngeal candidiasis. Guidelines for the empiric use of amphotericin B in these patients are provided.

UR - http://www.scopus.com/inward/record.url?scp=0020360770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020360770&partnerID=8YFLogxK

M3 - Article

C2 - 6958353

AN - SCOPUS:0020360770

VL - 50

SP - 2780

EP - 2784

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 12

ER -